Regulatory Compliance and Certification Services

The contract requires the timely provision of regulatory documentation such as Certificates of Pharmaceutical Product and Certificates of Free Sale for all medications supplied, ensuring full compliance with international inspection standards. This service is critical to facilitate the legal import and distribution of pharmaceuticals in foreign markets and must be delivered in accordance with the specific requirements of the receiving countries’ regulatory authorities. Issued under the U.S. Department of State through the US Embassy Manila, the subcontract is classified under NAICS code 541611 and is intended for a response by August 10, 2026. The contract supports diplomatic and public health objectives by ensuring that all pharmaceutical products meet stringent international regulatory and safety benchmarks, with documentation serving as mandatory proof of product legitimacy and market authorization.